Cargando…
Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience
BACKGROUND: Targeted next-generation sequencing (NGS) is frequently obtained at the University of California, Los Angeles (UCLA) for clinical characterization of CNS tumors. In this study, we describe the diagnostic reliability of the Foundation Medicine (FM) targeted NGS platform and its ability to...
Autores principales: | Ji, Matthew S, Eldred, Blaine S C, Liu, Regina, Pianka, Sean T, Molaie, Donna, Kevan, Bryan, Pan, Stephanie, Lai, Thomas J, Nguyen, Nhung T, Chow, Frances E, Yong, William H, Cox, Christopher D, Reeh, Devin N, Li, Tie, Liau, Linda M, Nghiemphu, Phioanh L, Cloughesy, Timothy F, Li, Gang, Lai, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034640/ https://www.ncbi.nlm.nih.gov/pubmed/32118206 http://dx.doi.org/10.1093/noajnl/vdaa009 |
Ejemplares similares
-
Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
por: Liu, Liang Yen, et al.
Publicado: (2019) -
Prognostic value of O(6)-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas
por: Lam, Keng, et al.
Publicado: (2022) -
A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients
por: Liu, Vicki, et al.
Publicado: (2023) -
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022) -
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)